Credit Valley Hospital

Media Release

June 6, 2008

BD logo

Credit Valley Receives Diamond Safety Award – First of its Kind Ever Presented!



FOR IMMEDIATE RELEASE: BD (Becton, Dickinson and Company) congratulates Credit Valley Hospital for achieving the first ever awarded Diamond level of the BD Safety Recognition Award. The BD Safety Recognition Award has been designed to recognize healthcare institutions for their commitment to providing a safer environment for staff and patients through the use of BD safety-engineered devices and programs. Sharps injuries can lead to the transmission of serious diseases such as hepatitis B, hepatitis C and HIV within the institution. Patient safety and the prevention of healthcare-associated infections (HAIs) are a major cause of morbidity and mortality. Credit Valley Hospital has taken a step forward in the prevention of both healthcare-associated infections and sharps injuries by implementing safety devices and programs.

BD is pleased to provide Credit Valley with an educational grant to further advance their efforts to provide a safer environment for their patients and healthcare workers.

In April of 2008, BD announced 18 hospitals across Canada as winners of the BD Safety Recognition Award. This is the fourth year of the BD Safety Recognition Program. “As our program grows, it is very empowering to see the positive affect that teamwork and partnership can have in promoting patient and healthcare worker safety.” said Anne Marie Carli, Manager of Patient Safety for BD.

BD is also pleased to recognize Credit Valley Hospital in Mississauga, Ontario, for achieving the diamond status, the highest award level in the program. This is the first diamond level award to be given in the history of the program. Credit Valley Hospital should be acknowledged for its leadership and proactive approach to preventing HAIs and needlestick injuries.

About BD

BD, a leading global medical technology company that manufactures and sells medical devices, instruments and reagents, is dedicated to improving people’s health throughout the world. BD is focused on improving drug therapy, enhancing the quality and speed of diagnosing infectious diseases, and advancing research and discovery of new drugs and vaccines. The Company’s capabilities are instrumental in combating many of the world’s most pressing diseases. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs approximately 28,000 people in approximately 50 countries throughout the world. The Company serves healthcare institutions, life science researchers, clinical laboratories, industry and the general public. For more information, please visit,


PDF File Download this release as PDF [17 kb]